The brain mineralocorticoid receptor: Greedy for ligand, mysterious in function

European Journal of Pharmacology

Volumn 405, Issue 1-3, 2000, Pages 235-249

  Reul, Johannes M H M ^a   Gesing, Angela ^a   Droste, Susanne ^a   Stec, Ingemar S M ^a   Weber, Anja ^a   Bachmann, Cornelius ^a   Bilang Bleuel, Alicia ^a   Holsboer, Florian ^a   Linthorst, Astrid C E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressants; Glucocorticoid receptor; Hypothalamic pituitary adrenocortical axis; Major depression; Mineralocorticoid receptor; Stress

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; ALDOSTERONE; ANTIDEPRESSANT AGENT; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR PROTEIN; TRITIUM;

ADRENALECTOMY; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; BRAIN LEVEL; CONFERENCE PAPER; CONTROL SYSTEM; CYTOSOL; DEPRESSION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGAND BINDING; MENTAL DISEASE; MICRODIALYSIS; NEGATIVE FEEDBACK; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; STRESS; TECHNIQUE; TISSUE DISTRIBUTION;

ANIMAL; BRAIN CHEMISTRY; HUMAN; LIGANDS; RECEPTORS, MINERALOCORTICOID;

EID: 0034730465     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00677-4     Document Type: Conference Paper

References (115)

1. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate
2. Corticoid receptors in rat brain: evidence for an aldosterone receptor
3. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin releasing factor
4. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor
5. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone
6. Nuclear localization of aldosterone in rat brain cells assessed by autoradiography
7. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors
8. Adrenal steroids and extinction behavior: antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone
9. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors
10. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain: therapeutic implications
11. Regional distinctions in the regulation of type I and type II adrenal steroid receptors in the central nervous system
12. Methods for receptor binding
13. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain
14. Male Fischer-344/N-rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age
15. Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation
16. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
17. Regulation of ACTH secretion: variations on a theme of B
18. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord
19. Brain corticosteroid receptor balance and homeostatic control
20. Why dexamethasone poorly penetrates in brain
21. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems
22. Differences in corticosterone and dexamethasone binding to rat brain and pituitary
23. Localization and role of transcortin-like molecules in the anterior pituitary
24. Brain corticosteroid receptor balance in health and disease
25. Uptake and binding of [3H]aldosterone by the anterior pituitary and brain regions in adrenalectomized rats
26. Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans
27. Differential activation of adrenal steroid receptors in neural and immune tissues of sprague dawley, fischer 344, and lewis rats
28. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans
29. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor
30. Adrenocortical steroids and the brain
31. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone
32. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
33. Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone
34. Corticotropin-releasing hormone-mediated rise in rat brain mineralocorticoid receptor density following acute stress: functional significance
35. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins
36. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone
37. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat
38. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis
39. Primary structure and expression of a functional human glucocorticoid receptor cDNA
40. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
41. Antidepressants and hypothalamic pituitary adrenocortical regulation
42. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders
43. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
44. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus
45. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro
46. Control of neuronal excitability by corticosteroid hormones
47. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons
48. Corticosteroid inhibition of ACTH secretion
49. Glucocorticoid receptor in magnocellular neurosecretory cells
50. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion
51. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity
52. Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature
53. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study
54. Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature and hypothalamic-pituitary-adrenocortical axis activity
55. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge
56. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice
57. Regulation of serotonin(1A), glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus- implications for the neurobiology of depression
58. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain
59. Selective retention of corticosterone by limbic structures in rat brain
60. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteroid receptor diversity
61. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice
62. Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol secretion
63. Corticosteroid receptor function is decreased in depressed patients
64. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders
65. Evidence for a specific mineralocorticoid receptor in rat pituitary and brain
66. Corticosteroids, receptors, and the organ-specific functions of 11ss-hydroxysteroid dehydrogenase
67. The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat
68. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
69. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors
70. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis
71. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies
72. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat
73. Type I adrenal steroid receptors prolong hippocampal long-term potentiation
74. RU 28362, a useful tool for the characterization of glucocorticoid and mineralocorticoid receptors
75. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
76. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
77. On the role of brain mineralocorticoid (type-I) and glucocorticoid (type-II) receptors in neuroendocrine regulation
78. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation
79. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis
80. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications
81. Neurotrophic ACTH analogue promotes plasticity of type I corticosteroid receptor in brain of senescent male rats
82. Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration
83. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary
84. Central action of adrenal steroids during stress and adaptation
85. Aging and the canine hypothalamic-pituitary-adrenocortical (HPA) axis
86. Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors
87. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
88. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
89. Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats
90. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides
91. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs
92. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands
93. In vitro binding of tritiated glucocorticoids directly on unfixed rat brain sections
94. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
95. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
96. The serum transport of steroid hormones
97. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy
98. Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat
99. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats
100. Adrenal steroid type-I and type-II receptor binding - estimates of in vivo receptor number, occupancy, and activation with varying level of steroid
101. Species-specificity of corticosteroid receptors in hamster and rat brains
102. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS
103. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone
104. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus
105. Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging
106. Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male Brown Norway rats
107. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus
108. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons
109. Specificity of the adrenal steroid receptor system in rat hippocampus
110. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression
111. Radioautographic study of the rat brain after injection of (1,2-3H)corticosterone
112. Mineralocorticoid receptor in rat kidney and hippocampus: characterization and quantitation by isoelectric focusing
113. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats
114. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression
115. Effects of the high-affinity corticotropin-releasing hormone receptor I antagonist R121919 in major depression: the first 20 patients treated